世界のポイントオブケア(POC)診断市場2022-2030:製品別(感染症、ブドウ糖検査、心臓マーカー)、最終用途別(診療所、家庭、病院)、地域別

【英語タイトル】Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GRV22JL096)・商品コード:GRV22JL096
・発行会社(調査会社):Grand View Research
・発行日:2022年5月25日
・ページ数:295
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

グランドビューリサーチ社は、世界のポイントオブケア(POC)診断市場規模が2022年から2030年の間に年平均6.8%成長し、2030年までに685.9億ドルに達すると予測しています。本調査レポートでは、ポイントオブケア(POC)診断の世界市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、新型コロナウイルス感染症の影響分析、競争分析、製品別(グルコース検査、Hb1ac検査、凝固検査、不妊・妊娠検査、その他)分析、最終用途別(診療所、病院、家庭、介護老人保健施設、研究所)分析、地域別分析、企業情報などを掲載しています。本調査レポートでは、Wipro Limited、Zoe Global Limited、Vocalis Health、Darwinai、Biocogniv, Inc.、Laipac Technology, Inc.、Gauss Surgical、Oxford Immune Algorithmics Ltd.、F. Hoffmann-La Roche Ltd.、Qiagenなどの企業情報が含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・新型コロナウイルス感染症の影響分析
・競争分析
・世界のポイントオブケア(POC)診断市場規模:製品別(グルコース検査、Hb1ac検査、凝固検査、不妊・妊娠検査、その他)
・世界のポイントオブケア(POC)診断市場規模:最終用途別(診療所、病院、家庭、介護老人保健施設、研究所)
・世界のポイントオブケア(POC)診断市場規模:地域別
・企業情報

ポイントオブケア(POC)診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のポイントオブケア(POC)診断市場規模は2030年までに685.9億米ドルに達する見込みです。2022年から2030年までのCAGRは6.8%で拡大する見込みです。Telehealth enabled POCTのような先進技術の導入が市場成長を促進する見込みです。さらに、高齢者人口の増加と利用しやすい在宅ケアのニーズが市場を牽引すると予測されます。

アフリカやラテンアメリカなどの新興国におけるPOCTの採用は、世界のPOCT市場の成長決定要因になると予想されます。当局は医療制度を分散化し、投資を増やしています。例えば、ケニアのアフリカ規制は、新しい機器の調達による施設の近代化に向けた政府の取り組みとして、マネージド機器サービスプロジェクトに346.7米ドルを割り当てました。保健省は、GEヘルスとフィリップスを選び、47カ国に機器を提供しました。同様に、ラテンアメリカでは体外診断用医薬品の検査が分散化され、特に感染症分野では、この地域の手頃な価格のPOCTに対する既存の需要を満たすために、民間企業が戦略的イニシアチブを取ることを奨励しています。

現在開発されているPOC機器や検査は、がん、妊娠、感染症など、さまざまな医療診断用途で採用されています。患者や医師は、POC検査を用いて病態をスクリーニングし、診断を確認し、患者の健康状態に基づいて適切な治療アプローチを設計します。しかし、医師、患者、介護者など、消費者によってその熱意は大きく異なります。このようなPOC診断製品のダイナミックな消費パターンは、経済的拡張性、経済的利益、国民皆保険制度の欠如にも起因しています。

COVID-19に照らし合わせると、世界中でロックダウンが実施されたため、患者が病院を訪れずに済むよう支援するバーチャル訪問や迅速診断検査が必要となりました。ロックダウン後、eヘルス戦略は、自動患者予約システム、検査結果送信システム、医療従事者のコミュニケーションシステム、企業や政府のための医療製品調達システムなど、優先順位と投資の新たな分野です。パンデミック後も、特に持病のある患者には在宅医療が優先されると予想されています。例えば、ニューロメトリックス社は、末梢神経障害のPOCTであるDPNCheckの事業開発のためのチームを任命しました。同チームは、医療市場における足跡を拡大し、メディケア・アドバンテージ集団に焦点を当てる責任を担っています。

ポイントオブケア(POC)診断市場レポートハイライト

- グルコース検査製品セグメントは2021年に第2位の収益シェアを獲得しました。糖尿病有病率の高さと、血糖値の常時モニタリングの必要性が、同分野の成長に寄与しています。

- COVID-19の在宅検査または自己検査が大きく普及していることから、在宅最終用途セグメントは予測期間中に大きく成長する見込み。POCTデバイスは使いやすく、患者のサンプルに含まれる簡便な標的分析物を検査するための近代的なラボインフラを義務付ける必要はありません。

- 2021年の世界市場は、新技術に対する需要の増加、主要プレイヤーの大規模なプール、高度な医療インフラにより、北米が支配しました。

- アジア太平洋地域は、がん、糖尿病、心血管疾患、感染症の有病率の上昇により、今後大幅な成長が見込まれます。可処分所得が限られている人口の増加は、この地域の主要プレーヤーにとって潜在的なターゲット市場です。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Market Categorization
1.4.2 Point-Of-Care Testing
1.4.2.1 Poc-End-Use Penetration Mapping
1.4.3 Pricing Analysis
1.4.4 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom Up Approach
1.7 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
1.9 List Of Primary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Market Summary
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Trends And Outlook
3.2 Market Segmentation And Scope
3.3 Parent Market Outlook
3.3.1 Related/Ancillary Market Outlook
3.3.1.1 Molecular Technology Intervention
3.3.1.1.1 Key Factors Considered For Analyzing Molecular Technology Interventions Across Poc Testing
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Introduction Of Clia Waived Tests
3.4.1.2 Rise In Funding From Government And Private Institutions
3.4.1.3 Growing Geriatric Population Base
3.4.1.4 Growing Prevalence Of Target Diseases
3.4.1.5 Growing Demand For Home Healthcare And The Introduction Of Advance Technology Enabled Products
3.4.2 Market Restraint Analysis
3.4.2.1 High Procedure Costs Coupled With Limited Adoption Of Poc Devices In Certain Emerging Regions
3.4.2.2 Presence Of Ambiguous Regulatory As Well As Reimbursement Framework For Primary Care Setting
3.4.3 Market Challenge Analysis
3.4.3.1 Poc Devices Pose Challenges In Maintaining The Quality Standards
3.4.4 Market Opportunity Analysis
3.4.4.1 Networking & Remote Access Integration Of Poc Diagnostics Products
3.4.4.1.1 Smartphone Orientation
3.4.4.1.2 Embedded Vision-Based Solutions
3.4.4.1.3 Digital Technologies
3.5 Penetration And Growth Prospect Mapping For Point Of Care Products, 2021
3.6 Swot By Pest Analysis
3.6.1 Political Landscape
3.6.2 Economic Landscape
3.6.3 Social Landscape
3.6.4 Technology Landscape
3.7 Industry Analysis – Porter’s
3.7.1 Bargaining Power Of Suppliers: Moderate
3.7.2 Bargaining Power Of Buyers: Moderate
3.7.3 Threat Of Substitution: Low
3.7.4 Threat Of New Entrants: Low
3.7.5 Competitive Rivalry: High
3.8 Major Deals & Strategic Alliances Analysis
3.8.1 Joint Ventures
3.8.2 Mergers & Acquisitions
3.8.3 Licensing & Partnership
3.9 Market Entry Strategies
3.10 Price-Cost-Margin Analysis For Point-Of-Care Testing
3.11 User Perspective Analysis
3.11.1 Consumer Behavior Analysis
3.12 Technology Overview
3.13 Poc Diagnostics: Market Influencers
3.13.1 High Sensitivity
3.13.2 Shift To Molecular Diagnostics
3.14 Product Positioning Analysis, 2021
3.14.1 Glucose Testing
3.14.2 Hb1ac Testing
3.14.3 Coagulation Testing
3.14.4 Fertility/Pregnancy
3.14.5 Infectious Disease
3.14.6 Cardiac Markers
3.14.7 Thyroid Stimulating Hormone
3.14.8 Haematology
3.14.9 Primary Care Systems
3.14.10 Decentralized Clinical Chemistry
3.14.11 Feces
3.14.12 Lipid Testing
3.14.13 Cancer Marker
3.14.14 Blood Gas/Electrolytes
3.14.15 Ambulatory Chemistry
3.14.16 Drug Of Abuse (Doa) Testing
3.14.17 Urinalysis/Nephrology
3.15 Regulatory Framework Analysis For U.S. Point Of Care Diagnostics
3.16 Regulatory Framework Analysis For Europe Point Of Care Diagnostics
3.17 Regulatory Framework Analysis For Japan Point Of Care Diagnostics
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.1.1 Covid-19 Point-Of-Care Diagnostics: Technology Overview
4.1.2 Covid-19 Point-Of-Care Diagnostics: Regulatory Overview
Chapter 5 Competitive Analysis.
5.1 Recent Developments & Impact Analysis, By Key Market Participants
5.2 Company/Competition Categorization
5.3 Vendor Landscape
5.3.1 Key Distributors Marketing Channels
5.3.1.1 Abbott Diagnostics
5.3.1.1.1 Abbott Diagnostics: Marketing Channels & Distribution Network For Poc
5.3.1.1.2 Alere Inc.
5.3.1.1.2.1 Alere: Marketing Channels & Distribution Network For Poc
5.3.1.2 Roche Diagnostics
5.3.1.2.1 Roche Diagnostics: Marketing Channels & Distribution Network For Poc
5.3.1.3 Siemens Healthcare
5.3.1.3.1 Siemens Healthcare: Marketing Channels & Distribution Network For Poc
5.3.1.4 Danaher Corporation
5.3.1.4.1 Danaher Corporation: Marketing Channels & Distribution Network For Poc
5.3.1.5 Instrumentation Laboratory Spa.
5.3.1.5.1 Instrumentation Laboratory Spa.: Marketing Channels & Distribution Network For Poc
5.3.1.6 Becton Dickinson
5.3.1.6.1 Becton Dickinson.: Marketing Channels & Distribution Network For Poc
5.3.2 Key Customers
5.4 Key Company Market Ranking, 2021
5.4.1 Company Size
5.4.2 Distribution Network
5.4.3 Product Portfolio
5.4.4 Segment Coverage
5.4.5 Geographic Presence
5.4.6 Collaborations
5.4.7 Conclusion
5.5 Public Companies
5.5.1 Number Of Products
5.5.2 Market Penetration
5.5.3 Strategic Initiatives
5.5.4 Segment Coverage
5.5.5 Geographical Presence
5.5.6 Competitive Dashboard Analysis
5.6 Market Differentiators
5.6.1 Application Trends
5.6.2 Technology Trends
5.6.3 Test Location Trends
5.6.4 End-Use Trends
5.6.5 Regional Trends
5.7 Private Companies
5.7.1 New Entrants/Emerging Players
5.8 Regional Mapping: Public And Private Companies
Chapter 6 Product Business Analysis
6.1 Point-Of-Care (Poc) Diagnostics Market: Product Movement Analysis
6.1.1 Glucose Testing
6.1.1.1 Glucose Testingpoint-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.2 Hb1ac Testing
6.1.2.1 Hb1ac Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.3 Coagulation Testing
6.1.3.1 Coagulation Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.4 Fertility/Pregnancy
6.1.4.1 Fertility/Pregnancy Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5 Infectious Diseases
6.1.5.1 Infectious Disease Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.2 Hiv Poc
6.1.5.2.1 Hiv Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.3 Clostridium Difficile Poc
6.1.5.3.1 Clostridium Difficile Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.4 Hbv Poc
6.1.5.4.1 Hbv Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.5 Pneumonia Or Streptococcus Associated Infections
6.1.5.5.1 Pneumonia Or Streptococcus Associated Infections Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.6 Respiratory Syncytial Virus (Rsv) Poc
6.1.5.6.1 Respiratory Syncytial Virus (Rsv) Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.7 Hpv Poc
6.1.5.7.1 Hpv Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.8 Influenza/Flu Poc
6.1.5.8.1 Influenza/Flu Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.9 Hcv Poc
6.1.5.9.1 Hcv Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.10 Mrsa Poc
6.1.5.10.1 Mrsa Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.11 Tb And Drug-Resistant Tb Poc
6.1.5.11.1 Tb And Drug-Resistant Tb Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.12 Hsv Poc
6.1.5.12.1 Hsv Poc Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.5.13 Covid-19
6.1.5.13.1 Covid-19 Diagnostics Market Estimates And Forecast, 2020 – 2030 (Usd Million)
6.1.5.14 Other Infectious Diseases
6.1.5.14.1 Other Infectious Disease Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.6 Cardiac Markers
6.1.6.1 Cardiac Markers Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.7 Thyroid Stimulating Hormone
6.1.7.1 Thyroid Stimulating Hormone Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.8 Hematology
6.1.8.1 Hematology Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.9 Primary Care Systems
6.1.9.1 Primary Care Systems Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.10 Decentralized Clinical Chemistry
6.1.10.1 Decentralized Clinical Chemistry Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.11 Feces
6.1.11.1 Feces Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.12 Lipid Testing
6.1.12.1 Lipid Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.13 Cancer Marker
6.1.13.1 Cancer Marker Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.14 Blood Gas/Electrolytes
6.1.14.1 Blood Gas/Electrolytes Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.15 Ambulatory Chemistry
6.1.15.1 Ambulatory Chemistry Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.16 Drug Of Abuse (Doa) Testing
6.1.16.1 Drug Of Abuse (Doa) Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.1.17 Urinalysis/Nephrology
6.1.17.1 Urinalysis/Nephrology Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 – 2030 (Usd Million)
Chapter 7 End-Use Business Analysis
7.1 Point-Of-Care (Poc) Diagnostics Market: End-Use Movement Analysis
7.1.1 Clinics
7.1.1.1 Point-Of-Care (Poc) Diagnostics Market For Clinics, 2018 – 2030 (Usd Million)
7.1.1.2 Pharmacy & Retail Clinics
7.1.1.2.1 Point-Of-Care (Poc) Diagnostics Market For Pharmacy & Retail Clinics, 2018 – 2030 (Usd Million)
7.1.1.3 Physician Office
7.1.1.3.1 Point-Of-Care (Poc) Diagnostics Market For Physician Office, 2018 – 2030 (Usd Million)
7.1.1.4 Urgent Care Clinics
7.1.1.4.1 Point-Of-Care (Poc) Diagnostics Market For Urgent Care Clinics, 2018 – 2030 (Usd Million)
7.1.1.5 Non-Practice Clinics
7.1.1.5.1 Point-Of-Care (Poc) Diagnostics Market For Non-Practice Clinics, 2018 – 2030 (Usd Million)
7.1.2 Hospitals
7.1.2.1 Point-Of-Care (Poc) Diagnostics Market For Hospitals, 2018 – 2030 (Usd Million)
7.1.3 Home
7.1.3.1 Point-Of-Care (Poc) Diagnostics Market For Home, 2018 – 2030 (Usd Million)
7.1.4 Assisted Living Healthcare Facilities
7.1.4.1 Point-Of-Care (Poc) Diagnostics Market For Assisted Living Healthcare Facilities, 2018 – 2030 (Usd Million)
7.1.5 Laboratory
7.1.5.1 Point-Of-Care (Poc) Diagnostics Market For Laboratory, 2018 – 2030 (Usd Million)
Chapter 8 Region Business Analysis
8.1 Point-Of-Care (Poc) Diagnostics Market: Regional Movement Analysis, 2021 & 2030
8.2 North America
8.2.1.1 North America Point-Of-Care (Poc) Diagnostics Market, 2018 – 2030 (Usd Million)
8.2.2 U.S.
8.2.3 Canada
8.3 Europe
8.3.1.1 Europe Point-Of-Care (Poc) Diagnostics Market, 2018 – 2030 (Usd Million)
8.3.2 Germany
8.3.3 U.K.
8.3.4 France
8.3.5 Italy
8.3.6 Spain
8.3.7 Russia
8.4 Asia Pacific
8.4.1.1 Asia Pacific Point-Of-Care (Poc) Diagnostics Market, 2018 – 2030 (Usd Million)
8.4.2 Japan
8.4.3 China
8.4.4 India
8.4.5 Australia
8.4.6 South Korea
8.5 Latin America
8.5.1.1 Latin America Point-Of-Care (Poc) Diagnostics Market, 2018 – 2030 (Usd Million)
8.5.2 Brazil
8.5.3 Mexico
8.6 Middle East & Africa (Mea)
8.6.1.1 Middle East & Africa Point-Of-Care (Poc) Diagnostics Market, 2018 – 2030 (Usd Million)
8.6.2 South Africa
8.6.3 Saudi Arabia
Chapter 9 Company Profile
9.1 Company Profiles
9.1.1 Wipro Limited
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.2 Zoe Global Limited
9.1.2.1 Company Overview
9.1.2.2 Product Benchmarking
9.1.3 Vocalis Health
9.1.3.1 Company Overview
9.1.3.2 Product Benchmarking
9.1.3.3 Strategic Initiatives
9.1.4 Darwinai
9.1.4.1 Company Overview
9.1.4.2 Product Benchmarking
9.1.4.3 Strategic Initiatives
9.1.5 Biocogniv, Inc.
9.1.5.1 Company Overview
9.1.5.2 Product Benchmarking
9.1.5.3 Strategic Initiatives
9.1.6 Laipac Technology, Inc.
9.1.6.1 Company Overview
9.1.6.2 Product Benchmarking
9.1.6.3 Strategic Initiatives
9.1.7 Gauss Surgical
9.1.7.1 Company Overview
9.1.7.2 Product Benchmarking
9.1.7.3 Strategic Initiatives
9.1.8 Oxford Immune Algorithmics Ltd.
9.1.8.1 Company Overview
9.1.8.2 Product Benchmarking
9.1.8.3 Strategic Initiatives
9.1.9 F. Hoffmann-La Roche Ltd.
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 Qiagen
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.1.10.4 Strategic Initiatives
9.1.11 Danaher Corporation
9.1.11.1 Company Overview
9.1.11.2 Beckman Coulter, Inc.
9.1.11.2.1 Company Overview
9.1.11.2.2 Radiometer Medical Aps
9.1.11.2.3 Hemocue Ab
9.1.11.3 Financial Performance
9.1.11.4 Product Benchmarking
9.1.11.5 Strategic Initiatives
9.1.12 Becton Dickinson (Bd)
9.1.12.1 Company Overview
9.1.12.2 Financial Performance
9.1.12.3 Product Benchmarking
9.1.12.4 Strategic Initiatives
9.1.13 Biomerieux Sa
9.1.13.1 Company Overview
9.1.13.2 Financial Performance
9.1.13.3 Product Benchmarking
9.1.13.4 Strategic Initiatives
9.1.14 Abbott
9.1.14.1 Company Overview
9.1.14.2 Alere, Inc.
9.1.14.2.1 Company Overview
9.1.14.3 Financial Performance
9.1.14.4 Product Benchmarking
9.1.14.5 Strategic Initiatives
9.1.14.5.1 Strategic Initiatives (Alere)
9.1.15 Siemens Healthcare Ag
9.1.15.1 Company Overview
9.1.15.2 Financial Performance
9.1.15.3 Product Benchmarking
9.1.15.4 Strategic Initiatives
9.1.16 Zoetis, Inc.
9.1.16.1 Company Overview
9.1.16.2 Abaxis
9.1.16.3 Company Overview
9.1.16.4 Financial Performance
9.1.16.4.1 Financial Performance (Abaxis)
9.1.16.5 Product Benchmarking
9.1.16.6 Strategic Initiatives
9.1.17 Instrumentation Laboratory
9.1.17.1 Company Overview
9.1.17.2 Accriva Diagnostics
9.1.17.2.1 Company Overview
9.1.17.3 International Technidyne Corporation (Itc)
9.1.17.3.1 Company Overview
9.1.17.4 Financial Performance (Instrumentation Laboratory)
9.1.17.4.1 Financial Performance (International Technidyne)
9.1.17.5 Product Benchmarking
9.1.17.6 Strategic Initiatives
9.1.18 Nova Biomedical
9.1.18.1 Company Overview
9.1.18.2 Financial Performance
9.1.18.3 Product Benchmarking
9.1.18.4 Strategic Initiatives
9.1.19 Trividia Health, Inc.
9.1.19.1 Company Overview
9.1.19.2 Financial Performance
9.1.19.3 Product Benchmarking
9.1.19.4 Strategic Initiatives
9.1.20 Quidel Corporation
9.1.20.1 Company Overview
9.1.20.2 Financial Performance
9.1.20.3 Product Benchmarking
9.1.20.4 Strategic Initiatives
9.1.21 Trinity Biotech
9.1.21.1 Company Overview
9.1.21.2 Financial Performance
9.1.21.3 Product Benchmarking
9.1.21.4 Strategic Initiatives
9.1.22 Sekisui Diagnostics
9.1.22.1 Company Overview
9.1.22.2 Product Benchmarking
9.1.22.3 Strategic Initiatives
9.1.23 Orasure Technologies, Inc.
9.1.23.1 Company Overview
9.1.23.2 Financial Performance
9.1.23.3 Product Benchmarking
9.1.23.4 Strategic Initiatives
9.1.24 Nipro
9.1.24.1 Company Overview
9.1.24.2 Financial Performance
9.1.24.3 Product Benchmarking
9.1.25 Spectral Medical Inc.
9.1.25.1 Company Overview
9.1.25.2 Financial Performance
9.1.25.3 Product Benchmarking

List of Tables

Table 1 List of secondary sources
Table 2 Examples: CLIA waived tests
Table 3 North America diabetes prevalence (national prevalence %), 2013 & 2035
Table 4 Europe diabetes prevalence (national prevalence %), 2013 & 2035
Table 5 Asia Pacific diabetes prevalence (national prevalence %), 2013 & 2035
Table 6 Latin America Diabetes Prevalence (national prevalence %), 2013 & 2035
Table 7 MEA and Africa diabetes prevalence (national prevalence %), 2013 & 2035
Table 8 CIS diabetes prevalence (national prevalence %), 2013 & 2035
Table 9 Description of POC devices for detection of diseases through specific salivary biomarkers
Table 10 Methods used for the evaluation of diagnostic toolboxes
Table 11 List of companies operating in the COVID-19 Point of Care diagnostics market
Table 12 Abbott Healthcare: List of Wholesalers & Distributors
Table 13 North America point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 14 North America point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 15 U.S. point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 16 U.S. point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 18 Canada point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 20 Europe point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 21 Germany point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 22 Germany point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 23 U.K. point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 24 U.K. point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 25 National and international requirements for quality management of Point of Care testing in France
Table 26 France point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 27 France point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 28 Italy point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 29 Italy point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 30 Spain point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 31 Spain point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 32 Russia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 33 Russia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 35 Asia Pacific point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 36 Japan point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 37 Japan point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 38 China point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 39 China point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 40 Some of the local glucose POC testing manufacturers in india
Table 41 India point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 42 India point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 43 Primary guidelines for glucose POC testing in Australia
Table 44 Australia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 45 Australia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 46 South Korea point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 47.South Korea point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 48 Latin America point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 49 Latin America point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 50 Brazil point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 51 Brazil point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 52 Mexico point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 53 Mexico point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East & Africa point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 56 South Africa point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 57 South Africa point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market revenue model
Fig. 5 POC segment penetration mapping
Fig. 6 Pricing analysis
Fig. 7 Market research approaches
Fig. 8 Value chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Market summary, 2021 (USD Million)
Fig. 12 Market trends & outlook
Fig. 13 Market segmentation & scope
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Point of care diagnostics market: Driver relevance analysis (Current & future impact)
Fig. 17 Shift in POC molecular diagnostic trends
Fig. 18 Global percentage of population, by age group, 2000 and 2050
Fig. 19 Population over the age of 65 years, by region, 2010 and 2050
Fig. 20 Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
Fig. 21 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (% increase)
Fig. 22 Point of care diagnostics market: Restraint relevance analysis (Current & future impact)
Fig. 23 Point of care diagnostics market: Challenge relevance analysis (Current & future impact)
Fig. 24 Point of care diagnostics market: Opportunity relevance analysis (Current & future impact)
Fig. 25 Accountable factors to ensure adequate accessibility of POC diagnostic solutions
Fig. 26 Penetration and growth prospect mapping
Fig. 27 Factors impacting market entry strategies
Fig. 28 Key market entry methods
Fig. 29 Consumption trends for POCT
Fig. 30 Product positioning analysis, 2021
Fig. 31 COVID-19 point of care (PoC) diagnostics market: Trend analysis
Fig. 32 COVID-19 Point of Care diagnostics: Technology landscape
Fig. 33 Recent Developments & Impact Analysis, by Key Market Participants
Fig. 34 Key market participants: Impact analysis, 2021
Fig. 35 Key market participants: Revenue-strategy mapping
Fig. 36 Company categorization
Fig. 37 Marketing channels
Fig. 38 Key customers
Fig. 39 Competitive Landscape POC Diagnostics - Major market participants
Fig. 40 Competitive dashboard analysis for public players
Fig. 41 Roche Distribution Presence
Fig. 42 Instrumentation Laboratory (Werfen Group) Distribution Presence
Fig. 43 Abbott Laboratories Distribution Network Coverage
Fig. 44 Alere Distribution Presence
Fig. 45 Siemens Healthcare Distribution Presence
Fig. 46 Danaher Distribution Presence (Radiometer, HemoCue, and Beckman Coulter)
Fig. 47 Becton Dickinson Presence
Fig. 48 Point of care (PoC) diagnostics market: Product outlook and key takeaways
Fig. 49 Point of care (PoC) diagnostics market: Product movement analysis
Fig. 50 Glucose testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Hb1Ac testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Coagulation testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Fertility/pregnancy point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Infectious disease point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 HIV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Clostridium Difficile POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 HBV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Pneumonia or streptococcus associated infections point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Respiratory syncytial virus (RSV) POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 HPV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 influenza/Flu POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 HCV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 MRSA POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 TB and drug-resistant TB POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 HSV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 COVID-19 diagnostics market, 2020 - 2030 (USD Million)
Fig. 67 Other infectious disease diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Cardiac markers point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Thyroid stimulating hormone point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Hematology point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Primary care systems point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Decentralized clinical chemistry point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Feces point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Lipid testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Cancer marker point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Blood gas/electrolytes point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Ambulatory chemistry point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Drug of abuse (DOA) testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Urinalysis/nephrology point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Point of Care (PoC) diagnostics market: End-use outlook and key takeaways
Fig. 81 Point of Care (PoC) diagnostics market: End-use movement analysis
Fig. 82 Point of Care (PoC) diagnostics market for clinics, 2018 - 2030 (USD Million)
Fig. 83 Point of Care (PoC) diagnostics market for pharmacy & retail clinics, 2018 - 2030 (USD Million)
Fig. 84 Point of Care (PoC) diagnostics market for physician office, 2018 - 2030 (USD Million)
Fig. 85 Point of Care (PoC) diagnostics market for urgent care clinics, 2018 - 2030 (USD Million)
Fig. 86 Point of Care (PoC) diagnostics market for non-practice clinics, 2018 - 2030 (USD Million)
Fig. 87 Point of Care (PoC) diagnostics market for hospitals, 2018 - 2030 (USD Million)
Fig. 88 Point of Care (PoC) diagnostics market for home, 2018 - 2030 (USD Million)
Fig. 89 Point of Care (PoC) diagnostics market for assisted living healthcare facilities, 2018 - 2030 (USD Million)
Fig. 90 Point of Care (PoC) diagnostics market for laboratory, 2018 - 2030 (USD Million)
Fig. 91 Regional market place: Key takeaway
Fig. 92 POC diagnostics market: Region movement analysis
Fig. 93 North America point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 94 U.S. point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 95 Canada point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 96 Europe point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 97 Germany point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 98 U.K. point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 99 France point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 100 Italy point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 101 Spain point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 102 Russia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 103 Asia Pacific point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 104 Japan point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 105 China point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 106 India point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 107 Australia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 108 South Korea point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 109 Latin America point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 110 Brazil point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 111 Mexico point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 112 Middle East & Africa point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 113 South Africa point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 114 Saudi Arabia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)

★調査レポート[世界のポイントオブケア(POC)診断市場2022-2030:製品別(感染症、ブドウ糖検査、心臓マーカー)、最終用途別(診療所、家庭、病院)、地域別] (コード:GRV22JL096)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のポイントオブケア(POC)診断市場2022-2030:製品別(感染症、ブドウ糖検査、心臓マーカー)、最終用途別(診療所、家庭、病院)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆